148 related articles for article (PubMed ID: 38138297)
1. Prognostic Value of Tumor Volume, Tumor Volume Reduction Rate and Magnetic Resonance Tumor Regression Grade in Rectal Cancer.
Pikūnienė I; Strakšytė V; Basevičius A; Žilinskas J; Ambrazienė R; Jančiauskienė R; Saladžinskas Ž
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138297
[No Abstract] [Full Text] [Related]
2. Prognostic Value of Tumor Regression Grade on MR in Rectal Cancer: A Large-Scale, Single-Center Experience.
Yoen H; Park HE; Kim SH; Yoon JH; Hur BY; Bae JS; Kim JH; Oh HJ; Han JK
Korean J Radiol; 2020 Sep; 21(9):1065-1076. PubMed ID: 32691542
[TBL] [Abstract][Full Text] [Related]
3. Modest agreement between magnetic resonance and pathological tumor regression after neoadjuvant therapy for rectal cancer in the real world.
Achilli P; Magistro C; Abd El Aziz MA; Calini G; Bertoglio CL; Ferrari G; Mari G; Maggioni D; Peros G; Tamburello S; Coppola E; Spinelli A; Grass F; Martin D; Hahnloser D; Salvatori A; De Simoni S; Sheedy SP; Fletcher JG; Larson DW
Int J Cancer; 2022 Jul; 151(1):120-127. PubMed ID: 35191540
[TBL] [Abstract][Full Text] [Related]
4. MRI tumor volume reduction rate vs tumor regression grade in the pre-operative re-staging of locally advanced rectal cancer after chemo-radiotherapy.
Neri E; Guidi E; Pancrazi F; Castagna M; Castelluccio E; Balestri R; Buccianti P; Masi L; Falcone A; Manfredi B; Faggioni L; Bartolozzi C
Eur J Radiol; 2015 Dec; 84(12):2438-43. PubMed ID: 26462793
[TBL] [Abstract][Full Text] [Related]
5. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
[No Abstract] [Full Text] [Related]
6. A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.
Battersby NJ; Dattani M; Rao S; Cunningham D; Tait D; Adams R; Moran BJ; Khakoo S; Tekkis P; Rasheed S; Mirnezami A; Quirke P; West NP; Nagtegaal I; Chong I; Sadanandam A; Valeri N; Thomas K; Frost M; Brown G
Trials; 2017 Aug; 18(1):394. PubMed ID: 28851403
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
8. Preoperative concurrent chemoradiotherapy MRI characteristics favouring pathologic complete response in patients with rectal cancer: Usefulness of MR T2-stage as an ancillary finding for predicting pathologic complete response.
Lee HJ; Chung WS; An JH; Kim JH
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):166-174. PubMed ID: 33319450
[TBL] [Abstract][Full Text] [Related]
9. Machine learning-based response assessment in patients with rectal cancer after neoadjuvant chemoradiotherapy: radiomics analysis for assessing tumor regression grade using T2-weighted magnetic resonance images.
Lee YD; Kim HG; Seo M; Moon SK; Park SJ; You MW
Int J Colorectal Dis; 2024 May; 39(1):78. PubMed ID: 38789861
[TBL] [Abstract][Full Text] [Related]
10. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
11. The role of MRI after neochemoradiotherapy in predicting pathological tumor regression grade and clinical outcome in patients with locally advanced rectal adenocarcinoma.
Niu S; Chen Y; Peng F; Wen J; Xiong J; Yang Z; Peng J; Bao Y; Ding L
Front Oncol; 2023; 13():1118518. PubMed ID: 37377906
[TBL] [Abstract][Full Text] [Related]
12. Modified 3-Point MRI-Based Tumor Regression Grade Incorporating DWI for Locally Advanced Rectal Cancer.
Lee MA; Cho SH; Seo AN; Kim HJ; Shin KM; Kim SH; Choi GS
AJR Am J Roentgenol; 2017 Dec; 209(6):1247-1255. PubMed ID: 28981353
[TBL] [Abstract][Full Text] [Related]
13. Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer.
Yeo SG; Kim DY; Kim TH; Jung KH; Hong YS; Chang HJ; Park JW; Lim SB; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):164-71. PubMed ID: 20004532
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters.
Hötker AM; Tarlinton L; Mazaheri Y; Woo KM; Gönen M; Saltz LB; Goodman KA; Garcia-Aguilar J; Gollub MJ
Eur Radiol; 2016 Dec; 26(12):4303-4312. PubMed ID: 26945761
[TBL] [Abstract][Full Text] [Related]
15. Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patients.
Cho MS; Kim H; Han YD; Hur H; Min BS; Baik SH; Cheon JH; Lim JS; Lee KY; Kim NK
Medicine (Baltimore); 2019 Aug; 98(35):e16614. PubMed ID: 31464897
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging tumor response score (mrTRS) predicts therapeutic effect and prognosis of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A prospective, multi-center study.
Guan Z; Sun RJ; Cao WT; Zhang HM; Yu T; Yu XP; Zhang JX; Zhang XY; Li XT; Zhou ZY; Zhao XM; Wen L; Sun YS
Radiother Oncol; 2020 Oct; 151():288-295. PubMed ID: 32890612
[TBL] [Abstract][Full Text] [Related]
17. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG
Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between Baseline Rectal Tumor Length and Magnetic Resonance Tumor Regression Grade Response to Chemoradiotherapy: A Subanalysis of the TRIGGER Feasibility Study.
Hodges N; Battersby N; Rao S; Brown G;
Ann Surg Oncol; 2023 Aug; 30(8):4729-4735. PubMed ID: 35771366
[TBL] [Abstract][Full Text] [Related]
19. The role of readout-segmented echo-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Yang L; Xia C; Liu D; Fang X; Pan X; Ma L; Wu B
Acta Radiol; 2020 Sep; 61(9):1155-1164. PubMed ID: 31924105
[TBL] [Abstract][Full Text] [Related]
20. Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.
Sclafani F; Brown G; Cunningham D; Wotherspoon A; Mendes LST; Balyasnikova S; Evans J; Peckitt C; Begum R; Tait D; Tabernero J; Glimelius B; Roselló S; Thomas J; Oates J; Chau I
Br J Cancer; 2017 Nov; 117(10):1478-1485. PubMed ID: 28934761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
